Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HIV Prevention Program: later-stage trial registry
2 of 4 indexed HIV Prevention Program trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
HIV Prevention Program: 4 US clinical trials tracked, 2 recruiting.
HIV Prevention Program is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Connecticut, running 1 of these trials.
Enrollment posture brief
Registry condition hiv-prevention-program
OPEN 2 | RECR 50% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
HIV Prevention Program lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HIV Prevention Program on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HIV Prevention Program is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
Yale University
NCT04738825
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
Duke University
NCT07218211
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women
Medstar Health Research Institute
NCT07318532
Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program
University of Connecticut
NCT04531670
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on HIV Prevention Program records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HIV Prevention Program trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HIV Prevention Program page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 HIV Prevention Program trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Connecticut sponsors the most HIV Prevention Program trials on record, review their full trial history before evaluating a specific study. See University of Connecticut's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HIV Prevention Program condition card totals 4 registered trials; most-linked intervention The women's PrEP Project (W-PrEP); top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.